Pages that link to "Q41052058"

The following pages link to The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine (Q41052058):

Displaying 21 items.

• Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window (Q26775243) (← links)
• The "stop" and "go" of nicotine dependence: role of GABA and glutamate (Q26824406) (← links)
• Targeting glutamate homeostasis for potential treatment of nicotine dependence (Q34502468) (← links)
• The role of metabotropic glutamate receptor 5 in the pathogenesis of mood disorders and addiction: combining preclinical evidence with human Positron Emission Tomography (PET) studies (Q35190052) (← links)
• Recent Advances in the Design and Development of Novel Negative Allosteric Modulators of mGlu5 (Q35210746) (← links)
• Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats (Q35291239) (← links)
• mGlu receptors and drug addiction. (Q35999502) (← links)
• Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography (Q36535202) (← links)
• The role of metabotropic glutamate receptors in addiction: Evidence from preclinical models (Q37858670) (← links)
• mGlu5 negative allosteric modulators: a patent review (2010-2012). (Q38075897) (← links)
• The role of mesoaccumbens dopamine in nicotine dependence (Q38338790) (← links)
• Accumbens Mechanisms for Cued Sucrose Seeking (Q38670605) (← links)
• Metabotropic glutamate receptor 5 as a potential target for smoking cessation (Q38795082) (← links)
• mGlu5 negative allosteric modulators: a patent review (2013 - 2016). (Q39076410) (← links)
• N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents (Q39955646) (← links)
• Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety (Q41891138) (← links)
• Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety (Q42728918) (← links)
• The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain (Q44138590) (← links)
• Reinforcement enhancement by nicotine in adult rats: behavioral selectivity and relation to mode of delivery and blood nicotine levels (Q47357549) (← links)
• Interactions of Glutamatergic Neurotransmission and Brain-Derived Neurotrophic Factor in the Regulation of Behaviors after Nicotine Administration (Q92817198) (← links)
• The role of the metabotropic glutamate receptor 5 in nicotine addiction (Q97880321) (← links)